Invention Grant
- Patent Title: Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors
-
Application No.: US15152404Application Date: 2016-05-11
-
Publication No.: US09650366B2Publication Date: 2017-05-16
- Inventor: Sougato Boral , Thomas C. Malone , Shimiao Wang , Sandhya Rao , Rong Yang
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: ALLERGAN, INC.
- Current Assignee: ALLERGAN, INC.
- Current Assignee Address: US CA Irvine
- Agent Jonathan Bass
- Main IPC: C07D405/14
- IPC: C07D405/14 ; C07D401/04 ; C07D409/14
Abstract:
This invention is directed to a compound of Formula I or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4 and X are as defined herein. The compounds of Formula I are useful as receptor tyrosine kinase (RTK) inhibitors and can be used to treat such diseases as cancer, blood vessel proliferative disorders, fibrotic disorders, mesangial cell proliferative disorders and metabolic diseases.
Public/Granted literature
- US20170096419A1 HETEROCYCLE-SUBSTITUTED PYRIDYL BENZOTHIOPHENES AS KINASE INHIBITORS Public/Granted day:2017-04-06
Information query
